This website uses cookies
Read our Privacy policy and Terms of use for more information.
From Biological Promise to Clinical Reality
Cholesterol Hypothesis
+8
How Biomarkers, Earlier Intervention, and Biological Stratification May Reshape Parkinson’s Disease Research
Parkinson's Research
+14
Why Timing, Heterogeneity, and Measurement Keep Defeating Neuroprotection
From Dopamine Replacement to Neural Repair
What Prodromal Markers and Biological Tests Can—and Cannot—Tell Us Before Motor Diagnosis
How one protein came to dominate Parkinson's disease research for more than two decades.
Alpha-Synuclein
+6
